Focus: Ambulatory Care/Pain Management
- Board Certified in Ambulatory Care Pharmacy
- PGY-2 Pain and Palliative Care Residency, Albany Stratton VA Hospital, Albany, NY
- PGY-1 Pharmacy Practice Residency, Sentara Health System, Norfolk, VA
- Pharm.D., Medical University of South Carolina, Charleston, SC
- Bachelor's of Science in Chemistry, Furman University, Greenville, SC
- Screening, Brief Intervention, Referral, Treatment (SBIRT)
- ACCP Pharmacogenomic Certification
- APhA Medication Therapy Management (MTM) Certification
- New York State Pharmacist Immunization Certification
COURSES TAUGHT AT ACPHS
- Pharmacotherapeutics, Pharmacology, & Medicinal Chemistry (PTPM) Neurology
- Critical Concepts in Pain Management Elective
- Integrated Problem Solving Workshop 3
- Integrated Problem Solving Workshop 4
- Ambulatory Care, Ambulatory Care/Pain Management Advanced Practice Experience
- Saratoga Community Health Center in Saratoga Springs, NY (ambulatory care/pain management/addiction)
Dr. Cleary is the director of the ACPHS pharmacogenomic certificate program. She is a member of the Clinical Pharmacogenomics Implementation Consortium (CPIC). She is also the Co-Director of Opioid Addiction Teaching Day (an interprofessional event with Albany Medical Center).
Recent national attention to the opioid epidemic has been a subject of increasing interest. Dr. Cleary has numerous posters and publications and has presented both locally and nationally on the topic of naloxone distribution, naloxone legislation, and risk mitigation strategies to reduce opioid abuse and misuse. Her interests include pain management, both opioid and non-opioid pharmacology, pharmacogenetics, as well as the integration of behavioral health and substance abuse management. Dr. Cleary also provides education throughout the curriculum on OTC pain management options for community pharmacists.
HONORS AND ACHIEVEMENTS
PAINWeek 2016 Scholarship Recipient
PROFESSIONAL ORGANIZATION MEMBERSHIPS
- American College of Clinical Pharmacy (ACCP)
- Society of Palliative Care Pharmacists
- American Pharmacists Association (APhA)
- Rho Chi alumna
- Phi Lambda Sigma alumna
Invited and Submitted for Publication March 2021. Badali M, Cleary J. Analgesics of the Future: Inside the Potential of Insulin-like Growth Factor (IGF). Practical Pain Management.
Accepted for Publication Engle A, Winans A, Demma L, Cleary J. The Divided Dose Approach to Perioperative Buprenorphine Management in Patients with Opioid Use Disorder. JOM Special Issue: Buprenorphine: Clinical and Public Policy Implications
Accepted for Publication Bettinger J, Quevedo H, Cleary J. Emerging Pharmacologic Mechanisms of Buprenorphine to Explain Analgesia Versus Adverse Effects. JOM Special Issue: Buprenorphine: Clinical and Public Policy Implications
Badali M, Cleary J. Role of Acid-Sensing Ion Channels (ASICs) in the Transduction of Pain. Practical Pain Management. 2021 May 21(3): https://www.practicalpainmanagement.com/treatments/pharmacological/non-opioids/analgesics-future-asic-inhibitors-igf-migraine-relief.
Fudin J, Bettinger J, Cleary J. The Science of Opioids: Evaluating New Therapies to Optimize Opioid Stewardship. Pharmacy Times Continuing Education. Posted January 2021: http://view.email.pharmacytimes.org/?qs=6f96554d55d13d32fd4040ee3affe06652f5fd0654006286a4f9fb0d0b8e27ea456b583a23f037740db04fc87b04939888c4855bccf19496c9737830e7d7030ce96c0c4a625d778d. Expires January 2022.
Mataraza A, Gamelli A, Cleary J. An Updated Look at the COVID-19 Vaccine Candidates- Storage, Distribution, and Barriers to Access. Guest blog article. Posted December 16, 2020: https://paindr.com/an-updated-look-at-the-covid-19-vaccine-candidates-storage-distribution-and-barriers-to-access/
Horan E, Healey A, Cleary J. Pharma Protects Patients Against Government: A COVID Vaccine Paradigm Shift. Guest blog article. Posted November 20, 2020: https://paindr.com/pharma-protects-patients-against-government-a-covid-vaccine-paradigm-shift/
Bettinger J, Cleary J, Fudin J. Amid COVID-19 Crisis, Pain Therapeutics Telehealth Services by Pharmacist Clinicians Fill Unique Void and Mitigate Risk. Medicine Access @ Point of Care 2020 August https://doi.org/10.1177/2399202620947035.
Bettinger J, Cleary J. The Rise in Tianeptine Abuse: Our Next Kratom Problem? Practical Pain Management 2020 March/April 20(2): 61-64.
Buscaglia M, Brandes H, Cleary J. Special Report: The Abuse Potential of Gabapentin and Pregabalin. Practical Pain Management. 2019 July 19(4): 50-53.
Cleary J, Fudin H. Should Emergency Naloxone be in Schools? Practical Pain Management 2019 May 19(3): 8-11.
Cleary J, Gerken M, Pratt A. Analgesics of the Future: Inside the Potential of Glial Cell Modulators. Practical Pain Management, 2019 March 19 (2): 56-59.
Gerken M, Cleary J. Opioid Absorption and Options Following Gastric Bypass Surgery. Guest blog article. Posted March 13, 2019: https://paindr.com/opioid-absorption-and-options-following-gastric-bypass-surgery/.
Prashad N, Cleary J. Galcanezumab: A New Calcitonin Gene-Related Peptide for Treating Migraine. Pharmacy Times, November 14, 2018.
Turtoro J, Hennig K, Cleary J, Fudin J. Looking for UDM Guidelines? Guest blog article, PainDr.com, March 23, 2018.
Fudin J, Cleary J, Sparkes S. Opioid Analgesics. In Pain Management Secrets, Argoff C et. al., ed., Chapter 38, Pg. 210-218, Fourth Ed. Elsevier Inc., 2018.
Fudin J, Cleary J, Sparkes S. Opioid Analgesics. In Argoff C et. al., ed., Pain Management Secrets. Chapter 38. Pg. 210-218. Fourth Ed. Elsevier Inc. 2018.
Cleary J, Watson A. Review of Naloxone Products, Patient’s Candidacy, and Legislation for Pharmacists. NYS Pharmacist- Publication of PSSNY. Vol 91 (4). August 2017.
Cleary J, Brennan Michael, Fudin J. Opioid rotation from Opana ER Following FDA Call for Removal. Practical Pain Management 2017 July/August. Available at: https://www.practicalpainmanagement.com/treatments/pharmacological/opio…
ASAM Handbook on Pain and Addiction. Section II. Diagnosing and Treating Pain and Addiction: General Principles. Chapter 9. Fudin, Cleary, Kominek, Brooks, Pham. 2017.
Fudin J, Pham T, Cleary J. Abuse-Deterrent Formulations: Clinical Applications and Utility in Chronic pain. Power-Pak C.E. Available at: https://www.powerpak.com/course/preamble/113829
Cleary J, Nicewicz K, Fudin J. Life-Saving Naloxone: Review of Currently Approved Products. Practical Pain Management 2016 September 16(7).
Atkinson TJ, Pratt Cleary J, Fudin J. 10 Pain Medication Myths: Challenges in Selecting the Appropriate Analgesic. Practical Pain Management. 2016 July/August 16(6): 63-70.
Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt Cleary, PharmD, Joseph Gottwald. Buprenoprhine, so misunderstood? Guest blog article, April 4, 2016.
Fudin J, Pratt Cleary J, Schatman ME. The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development. Journal of Pain Research. 2016 March; 9:153-156.
Jeffrey Fudin, Jacqueline Pratt Cleary, Joseph Gottwald. A Review of Buprenorphine Products. Pharmacy Times, 3/22/2016.
Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt Cleary, PharmD, Joseph Gottwald. Breaking Bad 2.0: Is it Possible to Synthesize Oxycodone from Naloxone? March 27, 2016.
Bettinger JJ, Cleary JP, Fudin J. What is the difference between Zohydro and Hysingla—hydrocodone extended release agents? Practical Pain Management. 2016 March; 16(2): 16-19.
Jacqueline Pratt Cleary. Rest Easy - Naloxone is in the House. Letters to the Editor. Practical Pain Management 2016; 16 (1): 14.
Jeffrey Fudin, Jacqueline Pratt Cleary, Mena Raouf. Risk Tools Helps Pharmacists Qualify Patients for Take-Home Naloxone. Pharmacy Times, 12/18/2015.
Timothy Atkinson, PharmD, BCPS, Jacqueline Pratt, PharmD, Jeffrey Fudin, BS, PharmD, FCCP. Challenges in Selecting Appropriate Analgesic Therapy: Ten Medication Myths. October 2015. Accepted for Publication: Journal of Pain Medicine.
Jeffrey Fudin, BS. PharmD, FCCP, Jacqueline Pratt, PharmD, Abigail Brooks, PharmD, BCPS, Courtney Kominek, PharmD, BCPS, CPE, Thien Pharm, BS, PharmD. Screening Tools When Using Opioids for Chronic Pain- textbook chapter, American Society of Addition Medicine Pain and Addiction Manual. Publisher: Oxford Press. Completed: September 2015.
Jeffrey Fudin, BS, PharmD, FCCP, FASHP, Jacqueline Pratt, PharmD, Mena Raouf, PharmD Candidate. Are you Kidding Me? Guest blog article. Posted September 18, 2015.
Jeffrey Fudin, BS, PharmD, FCCP, Thien Pharm, BS, PharmD, Jacqueline Pratt, PharmD. Abuse Deterrent Formulations: Clinical Applications and Utility in Chronic Pain. Postgraduate Healthcare Education, LLC (“PHE”) Continuing Education. Completed: July 2015.
KEYNOTE address at the Albany Stratton VA Residency Graduation for the class of 2020-2021.
A Pharmacists' Introduction to Clinical Pharmacogenomics. Continuing Education. NYS ACCP Virtual Presentation. November 2020.
Timely Topic on OUD Guidelines and the impact to the COVID-19 patient populations. Continuing Education. Albany College of Pharmacy and Health Sciences Virtual Presentation. October 2020.
An Introduction to Clinical Applications of Pharmacogenomics Part I & Part II. Continuing Education. Albany Medical Center Psychiatry Virtual Presentation Grand Rounds. October 2020.
All Hands on Deck: Rethinking Addiction as a Complex Disease Model. Continuing Education- KEYNOTE NYS ACCP presented with Dr. Joshua Zamer at Glen Sanders Mansion, Schenectady, NY. November 2019.
Pharmacogenomics: Introduction to Clinical Application. Presented at the Road from Nanomedicine to Precision Medicine, Albany, NY. October 2019.
Summary for CDC or Seedy Sea? What do the Guidelines Mean? DEBATE. Presented at the NJ Dental Society of Anesthesiology in Old Bridge, NY. October 2019.
Managing Buprenorphine Patients does NOT have to be Painful. Montana Pain Conference: Restoring the Person Within. Presented at Montana State University, Bozeman, MT. September 2019.
Managing Buprenorphine Patients does NOT have to be Painful. CPNP Community Webinar. September 2019.
Pharmacist Promotion of Opioid Patient Safety. Continuing Education Presented at PSSNY Mid-Year Winter Meeting. Albany, New York, January 26, 2018.
Pain Management - Select Review. Presented at Center for Rheumatology, Albany, NY September 2017.
PharmasKnowGenetics vs. Pharmacogenetics Unveiled. PainWeek 2017, Las Vegas, NV. September 7, 2017.
Interdisciplinary Integration of Next Generation Pharmacists. PainWeek 2017, Las Vegas, NV. September 8, 2017.
Hot Topics for Debate in Pain Management: Risk Mitigation, Multi-modal Analgesia, and Management of Frequent Flyers to the Emergency Room. Continuing Education Presented at New York State Council of Health-system Pharmacists. Bolton Landing, New York, April 28, 2017.
A Pharmacist’s Toolkit for Pain Management – Continuing Education. Presented to Mowhawk Valley Pharmacists Association, Utica, New York. March 12, 2016.
Opioid Induced Respiratory Depression and In-Home Naloxone Use: Application of the Risk Index for Overdose or Serious Opioid Induced Respiratory Depression (RIOSORD) Tool- Continuing Education. Presented at ACPHS at 2016 Alden March Bioethics Institute Clinical Ethics Conference, Albany, New York, November 19, 2016
Pharmacist’s Role in Naloxone Education and Distribution. Presented at Rho Chi and PLS joint meeting at Albany College of Pharmacy and Health Sciences, Albany, New York, November 2016.
Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool- Continuing Education. Presented at ACPHS at Annual Preceptor Training Day, Albany, New York, August 2016.
Risk Mitigation Strategies for Pharmacists to Combat the Opioid Epidemic- Continuing Education. Presented at Vermont Pharmacist Association (VPA) Spring Meeting, Burlington, VA, April 2016.
Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool- Continuing Education. Presented to VISN 2 pharmacists, students, and pharmacy support staff, Albany, NY, January 2016.
CONFERENCES AND PRESENTATIONS
Seo S, Bach K, Cabral K, Cleary J. Weaving Lifelong Advocacy into the Fabric of Students: APPE Student Consortium. AACP 2021 Annual Meeting, Virtual Poster Session & Roundtable Topic, virtual presentation. July 2021.
Cleary J, Yu D. Trending age-adjusted rates of opioid overdose deaths in New York counties following the 2014 enactment of medical marijuana. ACPHS Annual Student Research Symposium. Virtual Poster Session, virtual presentation. April 2021.
McCarthy K, Cleary J, Pierce T, Katche C, Cardone K. Naloxone Access and Distribution in Albany County Community Pharmacies. NYSCHP Annual Meeting. Virtual Poster Session, virtual presentation. March 2021.
Farrell J, Miller M, Hennig K, McCarthy K, Katche C, Cleary J. Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice: Patient Outcomes. NYSCHP Annual Meeting & Virtual Symposium, virtual presentations. March 2021.
Gamelli A, Yu D, Cleary J. Trending Prescription Opioid Related Deaths by State Following Legalization of Medical Cannabis for Chronic Pain Management and Opioid Use Disorder Indications. ASHP Midyear Clinical Meeting Virtual Poster Session, virtual presentation. December 2020.
Miller M, Hennig K, Cleary J, Kwon S, Citta A, French K, Moyer D, Powers K, Farrell J. Pharmacist Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice. NYSCHP Virtual Poster Session, virtual presentation. April 2020.
Seidl E, Cleary J. Pharmacist Driven Pharmacogenentic Testing: The Future of Individualized Medicine. ASHP Midyear Clinical Meeting, Las Vegas, NV. December 2019.
Hennig K, Miller M, Cleary J, Kwon S, Citta A, French K, Moyer D, Powers K, Farrell J. Pharmacist Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice. NYS ACCP, Albany, NY. November 2019.
Hadgu R, Parker W, Coriolan S, Cleary J, Cardone K. Knowledge of Blood Pressure and Consequences of High Blood Pressure Among Medically Underserved Patients. NKF, Boston, MA. May 2019.
Allard M, James N, Cleary J. Student Perception of the Opioid Epidemic at Albany College of Pharmacy and Health Sciences. 6th Annual ACPHS Student Research Symposium, Albany, NY. April 2019.
Gawdat M, Gawdat M, Bettinger J, Cleary J, Fudin F. Analysis of Variable Morphine Milligram Equivalent (MME) Threshold Trends by State. ASHP, Anaheim CA, December 2018.
Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. NYS ACCP Annual Meeting, Cooperstown NY, November 2018.
Higgins O, Cleary J. Pharmacy Driven Naloxone Distribution in Patients with High Risk for Opioid-Induced Respiratory Depression. ACPHS Student Summer Research Day, Albany NY, October 2018.
Bettinger J, Cleary J, Fudin J, Wegrzyn E. False-positive 6-mono acetyl morphine (6-MAM) Saliva Test Result in a Patient Taking Morphine and Aspirin: A Case Report. Pain Week, Las Vegas NV, September 2018.
Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? ICOO, Boston MA June 2018.
Mansour V, Chauhan C, Clark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. ICOO, Boston MA, June 2018.
Cleary J, Joyce A, Zedler B, Thomson H, Gudin J. Risk Factors for Prescription Opioid Overdose: Is It All Substance Use Disorder? AAPM, Vancouver Canada, April 2018.
Mansour V, Chauhan C, Clark L, Cleary J. Pharmacist Driven Naloxone Distribution in a Federally Qualified Health Center through Risk Index. International Conference on Opioids (ICOO), Boston MA, June 2018.